low-dose dexamethasone
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for low-dose dexamethasone, covering 2017-08-11 to 2021-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]